Drugs Made In America Acquisition Corp
DMAAU10.550USD
0.0000.00%
Handelsschluss 02/03, 16:00（ET）Kurse um 15 Minuten verzögert
0.00Marktkapitalisierung
--KGV TTM
mehr Informationen über Drugs Made In America Acquisition Corp Unternehmen
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition Corp Informationen
BörsenkürzelDMAAU
Name des UnternehmensDrugs Made In America Acquisition Corp
IPO-datumJan 28, 2025
CEOStockwell (Lynn)
Anzahl der mitarbeiter- -
WertpapierartUnit
Geschäftsjahresende- -
Addresse1 East Broward Boulevard
StadtFT LAUDERDALE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl33301
Telefon19548703099
Website
BörsenkürzelDMAAU
IPO-datumJan 28, 2025
CEOStockwell (Lynn)
Führungskräfte von Drugs Made In America Acquisition Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Umsatzaufteilung
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Drugs Made In America Acquisition LLC
17.88%
Kryger Capital Limited
1.28%
Wolverine Asset Management, LLC
0.55%
RiverNorth Capital Management LLC
0.44%
Clear Street Group Inc
0.20%
Andere
79.65%
Aktionäre
Aktionäre
Anteil
Drugs Made In America Acquisition LLC
17.88%
Kryger Capital Limited
1.28%
Wolverine Asset Management, LLC
0.55%
RiverNorth Capital Management LLC
0.44%
Clear Street Group Inc
0.20%
Andere
79.65%
Aktionärstypen
Aktionäre
Anteil
Corporation
17.88%
Investment Advisor
1.52%
Hedge Fund
0.61%
Investment Advisor/Hedge Fund
0.56%
Research Firm
0.20%
Andere
79.24%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
21
706.12K
14.40%
--
2025Q3
21
706.12K
14.40%
-280.00K
2025Q2
19
986.13K
14.72%
-2.41M
2025Q1
19
3.40M
0.80%
+3.21M
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Drugs Made In America Acquisition LLC
4.19M
17.88%
+4.19M
--
Feb 18, 2025
Kryger Capital Limited
300.00K
1.28%
+300.00K
--
Sep 30, 2025
Wolverine Asset Management, LLC
130.00K
0.55%
--
--
Sep 30, 2025
RiverNorth Capital Management LLC
102.37K
0.44%
-318.13K
-75.65%
Sep 30, 2025
Clear Street Group Inc
47.48K
0.2%
+47.48K
--
Sep 30, 2025
Clear Street LLC
45.92K
0.2%
+40.07K
+685.09%
Jun 30, 2025
Robinson Capital Management, LLC
30.00K
0.13%
--
--
Sep 30, 2025
Citadel Advisors LLC
11.96K
0.05%
-2.06K
-14.70%
Sep 30, 2025
UBS Financial Services, Inc.
18.39K
0.08%
--
--
Sep 30, 2025
Heights Capital Management, Inc.
--
0%
-650.00K
-100.00%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
CrossingBridge Pre-Merger SPAC ETF
0%
SPAC and New Issue ETF
0%
RiverNorth Enhanced Pre-Merger SPAC ETF
0%
CrossingBridge Pre-Merger SPAC ETF
Anteil0%
SPAC and New Issue ETF
Anteil0%
RiverNorth Enhanced Pre-Merger SPAC ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
